Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues $ 203,640
Operating expenses:    
Research and development 448,891 188,954
Occupancy 23,207 9,011
Depreciation and amortization 3,152 2,898
Officer compensation 354,051
Professional fees 217,701 1,328
Other operating expenses 112,547 4,985
Total operating expenses 1,159,549 207,176
Loss from operations (1,159,549) (3,536)
Other income (expense):    
Change in fair value of derivative 2,623,178
Interest income 2
Interest expense (34,939) (1,912)
Total other income (expense) 2,588,241 (1,912)
Income/(loss) before income taxes 1,428,692 (5,448)
Income tax expense
Net income/(loss) $ 1,428,692 $ (5,448)
Basic net income/(loss) per common share $ 0.03 $ 0.00
Diluted net income/(loss) per common share $ 0.02 $ 0.00
Basic weighted average common shares outstanding 44,864,716 41,400,000
Diluted weighted average common shares outstanding 69,244,021 41,400,000